Risk factors
In8bio (INAB) risk factors
Item 1A of every In8bio, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
71 risks, 4 new, 11 dropped, 19 reworded since the prior year. The company added specific clinical, manufacturing, and regulatory risks regarding its cancer therapies. It also incorporated administrative drug pricing policy uncertainties.
Filed Mar 12, 2026 - FY2024 10-K risk factors
78 risks. Substantial doubt about going concern threatens continued operations without significant additional capital raising.
Filed Mar 13, 2025